Skip to main content
Premium Trial:

Request an Annual Quote

Integrated DNA Technologies New Archer HRD Technology

Integrated DNA Technologies has launched new homologous recombination deficiency (HRD) assays to its Archer product portfolio. The company said the new HRD assays complement existing Archer microsatellite (MSI) and tumor mutational burden (TMB) assessment capabilities. The new assays include the VariantPlex HRD module, which can be run alone or spiked into other Archer panels, the VariantPlex Complete Solid Tumor v2 panel, and the VariantPlex Pan Solid Tumor v2 panel.